Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo.

O'Reilly, Terry

Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo. [electronic resource] - Anti-cancer drugs Jan 2011 - 58-78 p. digital

Publication Type: Journal Article

1473-5741

10.1097/CAD.0b013e3283400a20 doi


Animals
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Cell Line, Tumor
Cell Proliferation--drug effects
Cisplatin--administration & dosage
Deoxycytidine--administration & dosage
Dose-Response Relationship, Drug
Doxorubicin--administration & dosage
Drug Screening Assays, Antitumor
Drug Synergism
Epothilones--administration & dosage
Everolimus
Female
Fluorouracil--administration & dosage
HCT116 Cells
Humans
Mice
Mice, Nude
Paclitaxel--administration & dosage
Sirolimus--administration & dosage
TOR Serine-Threonine Kinases--antagonists & inhibitors
Xenograft Model Antitumor Assays
Gemcitabine